在血液中形成和消除可溶性纤维素和D-二次体
Anastasiia Udovenko1, Yevgen Makogonenko, Daria Korolova
1Anastasiia Udovenko, Leontovycha 9 St., Kyiv, 01054, Ukraine, nudovenko26@gmail.com.
Croatian medical journal
|January 3, 2024
概括
溶解纤维素形成微结块,通过等离子体激活产生D-二分体. 这项研究回顾了纤维素凝块形成和溶解机制,提出了D-二聚体和可溶性纤维素调节的模型.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 可溶性纤维素,不同于D-二元体,包括desA纤维素和纤维素原寡合体.
- 可溶性纤维素不会直接激活Glu-plasminogen,这表明它不是直接的D-二次元前体.
- 微血管溶解纤维素可以形成微结块,通过组织等离子素激活剂 (t-PA) 通过Glu-plasminogen激活启动D-二次体的形成.
研究的目的:
- 审查纤维素凝块形成和溶解的分子机制.
- 为了检查由t-PA.由纤维素依赖的Glu-plasminogen激活.
- 提出一个D-二聚体和可溶性纤维素的形成和消除的模型.
主要方法:
- 关于纤维解和微循环中的分子机制的文献综述.
- 纤维素凝块形成,溶解和Glu-plasminogen激活通路的分析.
- 开发一个概念模型,整合可溶性纤维素和D-二次体动态.
主要成果:
- 溶解纤维素水平通常超过了血中的D-二聚合物水平.
- 由可溶性纤维素寡合体形成的微结块刺激了t-PA介导的Glu-plasminogen激活,产生了Glu-plasmin和D-dimer.
- 溶解纤维素和D-二元体的血度由复杂的过程调节,包括超内皮转移和细胞吸收.
结论:
- 在健康和疾病中控制纤维素凝块形成和清除的精确机制需要进一步阐明.
- 一个拟议的模型突出了可溶性纤维素和D-二聚体的形成和消除的共同和独特途径.
- 了解这些动态对于理解血液静止和血栓形成至关重要.
更多相关视频
13:08Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
19.0K
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
13.8K
相关概念视频
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Extrinsic and Intrinsic Pathways of Hemostasis
7.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
702
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
702
Coagulation
6.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.7K
Introduction to Hemostasis
7.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.9K
Formation of the Platelet Plug
6.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.3K
